Fasciola hepatica: Humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice

2005 ◽  
Vol 110 (4) ◽  
pp. 374-383 ◽  
Author(s):  
Ana M. Espino ◽  
Antonio Osuna ◽  
Ramón Gil ◽  
George V. Hillyer
2016 ◽  
Vol 61 (2) ◽  
Author(s):  
Agnieszka Wesołowska ◽  
Anna Zawistowska-Deniziak ◽  
Luke J. Norbury ◽  
Przemysław Wilkowski ◽  
Kamil Januszkiewicz ◽  
...  

AbstractImmune responses of rats and sheep following vaccination with cDNA encoding phosphoglycerate kinase of


2003 ◽  
Vol 89 (3) ◽  
pp. 545-552 ◽  
Author(s):  
Ana M. Espino ◽  
George V. Hillyer

2000 ◽  
Vol 105 (2) ◽  
pp. 297-303 ◽  
Author(s):  
Michael B Reed ◽  
Richard A Strugnell ◽  
Michael Panaccio ◽  
Terry W Spithill

2019 ◽  
Vol 217 ◽  
pp. 109941
Author(s):  
Agnieszka Wesołowska ◽  
Katarzyna Basałaj ◽  
Anna Zawistowska-Deniziak ◽  
Kamil Januszkiewicz ◽  
Monika Kozak Ljunggren ◽  
...  

2006 ◽  
Vol 74 (8) ◽  
pp. 4932-4938 ◽  
Author(s):  
Daricel Torres ◽  
Ana M. Espino

ABSTRACT FhSAP-2 is a novel member of the Fasciola hepatica saposin-like protein family that induces protection in rabbits against a challenge infection. We investigated the presence of lineal B-cell epitopes within this protein using a set of overlapping synthetic peptides. Peptides were tested in enzyme-linked immunosorbent assays against sera from rabbits infected with F. hepatica. Two dominant epitopes were identified, which were also highly reactive with sera from mice infected with Schistosoma mansoni. These peptides may be suitable to incorporate into a polyepitope-based vaccine formulation against F. hepatica.


2001 ◽  
Vol 69 (5) ◽  
pp. 3041-3047 ◽  
Author(s):  
Audrey Tanghe ◽  
Sushila D'Souza ◽  
Valérie Rosseels ◽  
Olivier Denis ◽  
Thomas H. M. Ottenhoff ◽  
...  

ABSTRACT C57BL/6 mice were vaccinated with plasmid DNA encoding Ag85 fromMycobacterium tuberculosis, with Ag85 protein in adjuvant, or with a combined DNA prime-protein boost regimen. While DNA immunization, as previously described, induced robust Th1-type cytokine responses, protein-in-adjuvant vaccination elicited very poor cytokine responses, which were 10-fold lower than those observed with DNA immunization alone. Injection of Ag85 DNA-primed mice with 30 to 100 μg of purified Ag85 protein in adjuvant increased the interleukin-2 and gamma interferon (IFN-γ) response in spleen two- to fourfold. Further, intracellular cytokine analysis by flow cytometry also showed an increase in IFN-γ-producing CD4+ T cells in DNA-primed–protein-boosted animals, compared to those that received only the DNA vaccination. Moreover, these responses appeared to be better sustained over time. Antibodies were readily produced by all three methods of immunization but were exclusively of the immunoglobulin G1 (IgG1) isotype following protein immunization in adjuvant and preferentially of the IgG2a isotype following DNA and DNA prime-protein boost vaccination. Finally, protein boosting increased the protective efficacy of the DNA vaccine against an intravenousM. tuberculosis H37Rv challenge infection, as measured by CFU or relative light unit counts in lungs 1 and 2 months after infection. The capacity of exogenously given protein to boost the DNA-primed vaccination effect underlines the dominant role of Th1-type CD4+ helper T cells in mediating protection.


2019 ◽  
Vol 476 (21) ◽  
pp. 3281-3293 ◽  
Author(s):  
Elodie Lebredonchel ◽  
Marine Houdou ◽  
Hans-Heinrich Hoffmann ◽  
Kateryna Kondratska ◽  
Marie-Ange Krzewinski ◽  
...  

TMEM165 was highlighted in 2012 as the first member of the Uncharacterized Protein Family 0016 (UPF0016) related to human glycosylation diseases. Defects in TMEM165 are associated with strong Golgi glycosylation abnormalities. Our previous work has shown that TMEM165 rapidly degrades with supraphysiological manganese supplementation. In this paper, we establish a functional link between TMEM165 and SPCA1, the Golgi Ca2+/Mn2+ P-type ATPase pump. A nearly complete loss of TMEM165 was observed in SPCA1-deficient Hap1 cells. We demonstrate that TMEM165 was constitutively degraded in lysosomes in the absence of SPCA1. Complementation studies showed that TMEM165 abundance was directly dependent on SPCA1's function and more specifically its capacity to pump Mn2+ from the cytosol into the Golgi lumen. Among SPCA1 mutants that differentially impair Mn2+ and Ca2+ transport, only the Q747A mutant that favors Mn2+ pumping rescues the abundance and Golgi subcellular localization of TMEM165. Interestingly, the overexpression of SERCA2b also rescues the expression of TMEM165. Finally, this paper highlights that TMEM165 expression is linked to the function of SPCA1.


Sign in / Sign up

Export Citation Format

Share Document